(19)
(11) EP 4 824 095 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24837138.7

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 35/00(2006.01)
C07K 16/40(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2896; C07K 16/2809; C07K 2317/31; C07K 16/40; A61K 2039/505; A61P 35/00; A61K 2039/545; C07K 2317/33; C07K 2317/73; C07K 2317/92; C07K 2317/622
(86) International application number:
PCT/IB2024/062563
(87) International publication number:
WO 2025/126102 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 12.12.2023 US 202363609152 P

(71) Applicant: Janssen Biotech, Inc.
Horsham, PA 19044 (US)

(72) Inventors:
  • THORNTON, Katherine
    Raritan, New Jersey 08869 (US)
  • KALOTA, Anna
    Raritan, New Jersey 08869 (US)
  • SHAH, Nirav Raju
    Spring House, PA 19477 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) ENPP3 × CD3 BISPECIFIC ANTIBODIES AND USE THEREOF